12.77
Si Bone Inc 주식(SIBN)의 최신 뉴스
Jim Cramer on SI-BONE, Inc.: "We're not going to buy the money losers" - MSN
SI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership - MSN
Granahan Investment Management LLC Sells 224,678 Shares of SiBone $SIBN - MarketBeat
SiBone $SIBN Shares Purchased by First Light Asset Management LLC - MarketBeat
Divisadero Street Capital Management LP Trims Holdings in SiBone $SIBN - MarketBeat
Nishimura Mika, Si-Bone director, sells $56k in SIBN stock By Investing.com - Investing.com South Africa
Nishimura Mika, Si-Bone director, sells $56k in SIBN stock - Investing.com
SiBone (NASDAQ:SIBN) Director Mika Nishimura Sells 4,100 Shares - MarketBeat
Insider Sell: Mika Nishimura Sells 4,100 Shares of SI-BONE Inc (SIBN) - GuruFocus
[Form 4] SI-BONE, Inc. Insider Trading Activity - Stock Titan
Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers” - Insider Monkey
[144] SI-BONE, Inc. SEC Filing - Stock Titan
SiBone (NASDAQ:SIBN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Liquidity Mapping Around (SIBN) Price Events - Stock Traders Daily
Jim Cramer on SI-BONE: "This is a great, great speculation" - MSN
American Century Companies Inc. Acquires 521,683 Shares of SiBone $SIBN - MarketBeat
Earnings Recap: Can SI BONE Inc disrupt its industryGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Will SI BONE Inc. stock deliver strong dividend growthJuly 2025 Chart Watch & High Win Rate Trade Tips - Naître et grandir
SIBN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
First Eagle Investment Management LLC Has $7.13 Million Stock Position in SiBone $SIBN - MarketBeat
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - GlobeNewswire Inc.
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Si-Bone at TD Cowen Health Care Conference: Strategic Growth Plans - Investing.com
SIBN PE Ratio & Valuation, Is SIBN Overvalued - Intellectia AI
SIBN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SIBN SEC FilingsSi-Bone 10-K, 10-Q, 8-K Forms - Stock Titan
Why (SIBN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SI-BONE, Inc. (SIBN) Stock Analysis: Strong Buy Ratings Signal 57.73% Potential Upside - DirectorsTalk Interviews
Smith+Nephew signs distribution agreement with SI-BONE - MedTech Intelligence
Aug Technicals: What is the next catalyst for SI BONE Inc2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partne - The National Law Review
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partnership to Expand Access For Veterans & Wounded Warriors - EIN Presswire
SI‑BONE (SIBN) Losses Narrow In Q4 And Test Bearish Narratives On Profit Path - simplywall.st
SI-BONE, Inc. (NASDAQ:SIBN) Q4 2025 Earnings Call Transcript - Insider Monkey
Truist raises SI-BONE stock price target on strong quarter By Investing.com - Investing.com Australia
SI-Bone (SIBN) Submits Automatic Mixed Securities Shelf Filing - GuruFocus
Si-Bone files for mixed shelf size not disclosed - marketscreener.com
Si-Bone Files For Mixed Shelf Size Not Disclosed - TradingView
Si-Bone inks 50,000-square-foot lease in San Jose - The Business Journals
SI-BONE Q4 2025 slides: profitability milestone as revenue tops $200M - Investing.com South Africa
SI-BONE (NASDAQ: SIBN) files shelf to register common, preferred, debt and warrants - Stock Titan
SI-BONE (SIBN) 2025 10-K shows narrowing losses and $3.5B+ market - Stock Titan
TD Cowen Maintains Buy Rating for SIBN, Raises Price Target | SI - GuruFocus
Truist raises SI-BONE stock price target on strong quarter - Investing.com Nigeria
SiBone (NASDAQ:SIBN) Shares Gap Up on Earnings Beat - MarketBeat
SI-BONE, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Truist Securities Adjusts Price Target on SI-BONE to $24 From $23, Maintains Buy Rating - marketscreener.com
SI-Bone: Early Profitability and 2026 Growth Catalysts Underpin Buy Rating and $22 Price Target - TipRanks
SI-BONE revenue up 15% to USD 56.3M in Q4 2025 - Medical Buyer
Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio - Yahoo Finance
SI-BONE Inc (SIBN) Q4 2025 Earnings Call Highlights: Record Reve - GuruFocus
SiBone Q4 2025 Earnings Call Transcript - MarketBeat
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings Call Summary | Si-Bone(SIBN.US) Q4 2025 Earnings Conference - 富途牛牛
SI-BONE (SIBN) Q4 2025 Earnings Call Transcript - The Globe and Mail
SI-BONE Inc reports results for the quarter ended December 31Earnings Summary - TradingView
자본화:
|
볼륨(24시간):